PRISM0CAL B22K0/0 7.14 G — DIN 02441691
SODIUM CHLORIDE : 7.14 G MAGNESIUM CHLORIDE : 3.05 G SODIUM BICARBONATE : 2.12 G · VANTIVE ULC · SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is PRISM0CAL B22K0/0?
PRISM0CAL B22K0/0 7.14 G contains SODIUM CHLORIDE : 7.14 G MAGNESIUM CHLORIDE : 3.05 G SODIUM BICARBONATE : 2.12 G. It is listed in the Health Canada Drug Product Database under DIN 02441691, held by VANTIVE ULC, supplied as SOLUTION for INTRAVENOUS ; HAEMODIALYSIS administration. Health Canada currently lists it as marketed, status dated 19-Apr-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is PRISM0CAL B22K0/0 used for?
Prism 0CAL B22K0/0 is indicated for: • treatment of acute renal failure as replacement solution in hemofiltration or hemodiafiltration and as dialysis solution in hemodialysis or hemodiafiltration in continuous renal replacement therapy (CRRT). • patients who have tendency to hyperkalaemia and/or hypercalcemia, • treatment in case of drug poisoning with dialyzable or filterable substances.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Is there a generic Hemofiltrates in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
Only one market authorization holder has a Canadian DIN containing Hemofiltrates — 2 DINs, of which 2 are currently marketed. There is no second Canadian source today, so a supply interruption on this holder has no domestic substitute at the same molecule.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| VANTIVE ULC | 2 | 2 | PRISM0CAL B22K0/0, REGIOCIT | Sourceable in Canada |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 7.14 G |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAVENOUS ; HAEMODIALYSIS |
| Pack configuration (monograph) | 2 x 5000 mL in a box |
| Storage | Store between 4°C and 30°C. Do not refrigerate. Protect from freezing. |
| Shipping class | Cold chain — validated shipper with temperature monitoring |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Cold chain. This product is stored refrigerated. Nexara ships it on a validated cold chain with temperature monitoring; a delivery address that cannot receive and store it at 2–8 °C on arrival must be flagged before the order is placed.
Substance and classification
| Active substance | Hemofiltrates |
|---|---|
| ATC code | B05ZB |
| AHFS class | 08:12.16.08 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02441691 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2441691 |
| Brand name | PRISM0CAL B22K0/0 |
| Generic / active ingredient | SODIUM CHLORIDE : 7.14 G MAGNESIUM CHLORIDE : 3.05 G SODIUM BICARBONATE : 2.12 G |
| Market authorization holder | VANTIVE ULC |
| Health Canada schedule | Ethical |
| ATC code | B05ZB |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05ZB |
| Current status | MARKETED |
| Status date | 19-Apr-2024 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
2 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| REGIOCIT | 5.03 G | SOLUTION | VANTIVE ULC | MARKETED | 02496755 |
2 · Same class — other molecules in ATC B05ZB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Hemofiltrates | PRISM0CAL B22K0/0 · REGIOCIT | 2 | 2 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05Z
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05ZA | Hemodialytics, Concentrates | 588 | 117 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.